CONMED (CNMD) HR executive awarded RSUs and stock options under 2025 plan

Rhea-AI Filing Summary

Ferrell John D. reported acquisition or exercise transactions in this Form 4 filing.

CONMED Corp Executive Vice President of HR John D. Ferrell reported equity awards in the form of restricted stock units and stock options. He was granted 9,282 RSUs, each representing one share of common stock, which generally vest over three years in 33%, 33%, and 34% annual installments. He also received options to purchase 10,999 shares of common stock, generally vesting in equal 25% installments over four years under the 2025 Long-Term Incentive Plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ferrell John D.

(Last) (First) (Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO FL 33773

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President - HR

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
RSUs (Restricted Stock Units)	$0	03/02/2026		A		9,282		(1)	03/02/2036	Common Stock	9,282	$0	9,282	D
Options To Purchase Common Stock	$45.79	03/02/2026		A		10,999		(2)	03/02/2036	Common Stock	10,999	$0	10,999	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

2. The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.

	/s/ Thomas Fistek for John D. Ferrell by Power of Attorney	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CONMED Corp (CNMD) report for John D. Ferrell?

CONMED reported that Executive Vice President of HR John D. Ferrell received grants of restricted stock units and stock options. These awards were reported as acquisitions, not open-market purchases or sales, under the company’s 2025 Long-Term Incentive Plan.

How many RSUs did John D. Ferrell receive from CONMED Corp (CNMD)?

John D. Ferrell received 9,282 restricted stock units from CONMED. Each RSU represents a contingent right to one share of common stock and generally vests over three years in 33%, 33%, and 34% installments after the grant date.

What are the vesting terms of John D. Ferrell’s CONMED (CNMD) RSU grant?

The RSU grant generally vests over three years. About 33% of the 9,282 RSUs vest one year after the grant date, another 33% vest in the second year, and the remaining 34% vest in the third year, subject to the plan’s conditions.

How many stock options did John D. Ferrell receive from CONMED (CNMD)?

He received options to purchase 10,999 shares of CONMED common stock. These options were granted at no cost on the grant date and are reported as derivative securities under the company’s 2025 Long-Term Incentive Plan.

What are the vesting terms of John D. Ferrell’s CONMED (CNMD) stock options?

The stock options generally vest in equal 25% installments over four years. The first 25% vests one year after the grant date, with additional 25% portions vesting in each of the next three years, consistent with the plan’s provisions.

Are John D. Ferrell’s CONMED (CNMD) equity awards direct or indirect holdings?

The reported RSUs and stock options are classified as direct holdings. The Form 4 indicates direct ownership for both awards, with no footnote stating that another entity or person holds voting or investment authority over these securities.